BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3139598)

  • 1. The expression of tumor rejection antigen on rat fetus fibroblasts transformed by the ras oncogene.
    Okubo M; Yagihashi A; Torigoe T; Konno A; Sato N; Kikuchi K
    Jpn J Cancer Res; 1988 Jul; 79(7):850-6. PubMed ID: 3139598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of cell surface transformation-associated antigens TAAs on activated oncogene-transfected rat fibroblast and antitumor immunity by hosts].
    Sato N; Yagihashi A; Konno A; Torigoe T; Kikuchi K
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):653-61. PubMed ID: 2705790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the transformation-associated cell surface antigen expressed on the rat fetus-derived fibroblast.
    Yagihashi A; Sato N; Torigoe T; Okubo M; Konno A; Takahashi N; Yamashita T; Fujinaga K; Kuzumaki N; Kikuchi K
    Cancer Res; 1988 May; 48(10):2798-804. PubMed ID: 3162824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat- or stress-inducible transformation-associated cell surface antigen on the activated H-ras oncogene-transfected rat fibroblast.
    Konno A; Sato N; Yagihashi A; Torigoe T; Cho JM; Torimoto K; Hara I; Wada Y; Okubo M; Takahashi N
    Cancer Res; 1989 Dec; 49(23):6578-82. PubMed ID: 2555046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor rejection antigens on BALB3T3 cells transformed by activated oncogenes.
    Torigoe T; Sato N; Takashima T; Cho JM; Tsuboi N; Qi WM; Hara I; Wada Y; Takahashi N; Kikuchi K
    J Immunol; 1991 Nov; 147(9):3251-8. PubMed ID: 1919013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer target molecules associated with the transformation of the oncogene-transfected fibroblast.
    Cho JM; Sato N; Yagihashi A; Konno A; Hara I; Konn S; Torigoe T; Qi W; Takashima T; Takahashi N
    Cancer Res; 1991 Aug; 51(16):4250-6. PubMed ID: 1868445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-10 inhibited the expression of tumor antigens and major histocompatibility complex antigen on EJ-ras oncogene transformants.
    Tsuruma T; Yagihashi A; Torigoe T; Okada Y; Sato N; Kikuchi K; Hirata K
    Artif Organs; 1996 Aug; 20(8):895-7. PubMed ID: 8853802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of natural killer cell cytotoxicity by cell growth-related molecules.
    Tamura Y; Takashima S; Cho JM; Qi W; Kamiguchi K; Torigoe T; Takahashi S; Hirai I; Sato N; Kikuchi K
    Jpn J Cancer Res; 1996 Jun; 87(6):623-30. PubMed ID: 8766527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 70 kDa heat shock cognate protein is a transformation-associated antigen and a possible target for the host's anti-tumor immunity.
    Tamura Y; Tsuboi N; Sato N; Kikuchi K
    J Immunol; 1993 Nov; 151(10):5516-24. PubMed ID: 8228242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.
    Seliger B; Harders C; Lohmann S; Momburg F; Urlinger S; Tampé R; Huber C
    Eur J Immunol; 1998 Jan; 28(1):122-33. PubMed ID: 9485192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse embryo fibroblasts transformed by activated ras or dominant-negative p53 express cross-reactive tumor rejection antigens.
    Appleman LJ; Uyeki J; Frey AB
    Int J Cancer; 1995 Jun; 61(6):887-94. PubMed ID: 7540599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-10 reduces natural killer sensitivity and downregulates MHC class I expression on H-ras-transformed cells.
    Tsuruma T; Yagihashi A; Torigoe T; Sato N; Kikuchi K; Watanabe N; Hirata K
    Cell Immunol; 1998 Mar; 184(2):121-8. PubMed ID: 9630838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of peptide antigens in the cytotoxicity between 70-kDa heat shock cognate protein-like molecule and CD3+, CD4-, CD8-, TCR-alpha beta- killer T cells.
    Takashima S; Sato N; Kishi A; Tamura Y; Hirai I; Torigoe T; Yagihashi A; Takahashi S; Sagae S; Kudo R; Kikuchi K
    J Immunol; 1996 Oct; 157(8):3391-5. PubMed ID: 8871636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged inhibition by X-rays of DNA synthesis in cells obtained by transformation of primary rat embryo fibroblasts with oncogenes H-ras and v-myc.
    Wang Y; Iliakis G
    Cancer Res; 1992 Feb; 52(3):508-14. PubMed ID: 1732037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rat embryo cells immortalized with transfected oncogenes are transformed by gamma irradiation.
    Endlich B; Salavati R; Sullivan T; Ling CC
    Radiat Res; 1992 Dec; 132(3):301-11. PubMed ID: 1475353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal cosegregation of tumorigenicity with overexpression of c-myc and transforming growth factor alpha genes in chemically transformed rat liver epithelial cells.
    Lee LW; Raymond VW; Tsao MS; Lee DC; Earp HS; Grisham JW
    Cancer Res; 1991 Oct; 51(19):5238-44. PubMed ID: 1717143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the transformed and neoplastic phenotype of rat fibroblasts by MHC-I gene expression.
    Gattoni-Celli S; Strauss RM; Willett CG; Pozzatti R; Isselbacher KJ
    Cancer Res; 1989 Jun; 49(12):3392-5. PubMed ID: 2655894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.
    Chen PW; Ananthaswamy HN
    J Immunol; 1993 Jul; 151(1):244-55. PubMed ID: 8326126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Ly-6.2 and Thy-1 antigens on NIH 3T3 cells suppressed after transformation with activated human ras-oncogenes.
    Ivanyi D; Janssen JW; Collard JG
    Int J Cancer; 1986 Oct; 38(4):575-80. PubMed ID: 2875953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.